Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. - Wikidata - awgldk - TriplyDB

Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.

Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.

http://www.wikidata.org/entity/Q50663741

about

Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage A secreted form of the asialoglycoprotein receptor, sH2a, as a novel potential noninvasive marker for liver fibrosis Non invasive tools for the diagnosis of liver cirrhosis.Non-invasive assessment of liver fibrosis in chronic hepatitis C.Impact of contacting study authors to obtain additional data for systematic reviews: diagnostic accuracy studies for hepatic fibrosis.A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis Prevalence of cirrhosis in patients with thrombocytopenia who receive bone marrow biopsy.Processes to manage analyses and publications in a phase III multicenter randomized clinical trial Matrix Mechanosensing: From Scaling Concepts in 'Omics Data to Mechanisms in the Nucleus, Regeneration, and Cancer.Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C.The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.Image analysis of liver collagen using sirius red is more accurate and correlates better with serum fibrosis markers than trichrome.The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases.Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors.Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients.Identification of Enolase 1 and Thrombospondin-1 as serum biomarkers in HBV hepatic fibrosis by proteomics YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C Antifibrotic effect of aloe vera in viral infection-induced hepatic periportal fibrosis Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.Serum albumin is present at higher levels in alcoholic liver cirrhosis as compared to HCV-related cirrhosis Intrahepatic Fat Content and Markers of Hepatic Fibrosis in Obese Children.Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis.Serum hyaluronic acid as a noninvasive marker of hepatic fibrosis in chronic hepatitis B Demographics of a large cohort of urban chronic hepatitis C patients.YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?YKL-40: a potential biomarker for osteoarthritis.Metrically measuring liver biopsy: a chronic hepatitis B and C computer-aided morphologic description Clinical Benefits of Biochemical Markers of Fibrosis in Egyptian Children With Chronic Liver Diseases.Plasma YKL-40: a potential new cancer biomarker?The significance of YKL-40 protein in liver fibrosis.Circulating CO3-610, a degradation product of collagen III, closely reflects liver collagen and portal pressure in rats with fibrosis.Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools.Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases.Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient.Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation.A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients.The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis.Assessment of liver fibrosis: the relationship between point shear wave elastography and quantitative histological analysis.

P2860

Q26752723-0A9E1196-3FA7-4CDF-809C-1B122304B3B4 Q26773289-CB4A4CBB-F251-4B50-808E-889EE92DA766 Q28742875-C11AEC8D-ACCA-45D3-96F0-AF3B8284C7FC Q30421450-0CED409D-FE98-43F4-87F1-0BC8BBCF0EE1 Q30474738-63AC4A5C-8B36-4AFE-9A0C-D3386EB805DF Q30853941-2D691C1A-C730-4E92-BBE6-228528968C0B Q31157282-FD0FF116-862B-4CF9-A204-F8947F9543E3 Q33402491-522E2EC3-1028-4B6F-92F8-1DF236502AC9 Q33694159-AE6BBF7A-A618-4D10-AB1F-917E537C09FD Q33726992-7695646D-D0B4-487C-B962-55915ABFD7F4 Q33905922-F96989AF-7487-4ADF-A682-3404C5334AC2 Q33999294-C7344199-E08E-452A-93DB-4E8D477FD68D Q34036477-CD57A220-1E21-4911-88B0-3965FDC22C53 Q34479904-C4D70536-D4FD-40B8-8228-3A65D5BAB17F Q34704820-CCEF5048-15F5-4665-88CA-600431CC78E3 Q34749550-F0867963-50D0-4331-BC63-A02B50A11006 Q34812703-2F46B121-FBF2-4A6E-949C-ECDD52EC0D09 Q35823055-73AF6702-18DB-4A2B-B5DA-FF926D3C32D1 Q35929150-24A60ACB-CB00-41FE-BB99-4E369421609D Q36049926-1725E38A-1CBA-4CA0-898F-203D8B27C77C Q36225199-2D937369-4324-41B0-A170-A596789D2FC9 Q36591048-256231B2-7ABE-42AC-8E59-960DE793EA97 Q37086216-698CFE4D-B1F3-4708-8D30-94ADEDA7F6B3 Q37155215-01CEFB74-9114-4869-BB76-C8F59AF4C5BC Q37243587-B58AB7F2-D6EF-4913-B4EA-A95938A67090 Q37278212-6DE81653-6479-43DB-9AFD-BF65331E0C87 Q37334247-044C548C-9293-4ED4-9093-2E774EB36245 Q37392423-D9444A08-A661-459A-87CF-EBD93A614F64 Q37423058-F98A2BEA-BF04-4F74-AAA8-DB4B9FF6C894 Q37477801-0D70CFD7-F74C-4605-8AF8-43C721B86149 Q37605869-5F9734D0-9B7B-4D88-917C-875F223EE7FF Q38179983-9F42E3DD-0618-42E1-BA9F-CCDDD27C2148 Q38366999-BB3A01AF-ED20-4C6A-BB81-F23B5D6F2195 Q38689700-4213B997-5275-43AC-9745-283901A15AB4 Q38836316-38AA5421-FD78-4255-AE70-9E1407DEB8DA Q39868791-8570056F-9418-4360-A082-3AD4B4CDCC17 Q39968802-F919FA02-16DD-4CB2-9694-69FC4C92F31B Q40056735-278FECFB-EC24-4265-A990-171739552CCA Q40072990-81AC791E-FCB1-4CDB-8FCB-CFAA570AD46C Q40224299-886A726D-A17E-4113-BB84-D23A77DD55D6

P2860

Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.

http://www.wikidata.org/entity/Q50663741

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Relationship of serum fibrosis ...... advanced chronic hepatitis C.

@en

Relationship of serum fibrosis ...... advanced chronic hepatitis C.

@nl

type

label

Relationship of serum fibrosis ...... advanced chronic hepatitis C.

@en

Relationship of serum fibrosis ...... advanced chronic hepatitis C.

@nl

prefLabel

Relationship of serum fibrosis ...... advanced chronic hepatitis C.

@en

Relationship of serum fibrosis ...... advanced chronic hepatitis C.

@nl

P1433

Q50663741-187C254B-AE0C-4D95-8238-3A652E56657B

P1476

Q50663741-A5D2FF89-60DB-469D-AAB3-3BF561B6208A

P2093

Q50663741-0EE6D64C-492F-4CBB-8AF4-2FC719F8F002

Q50663741-0F19B34F-B9F9-4E82-9E6B-213FF43C428F

Q50663741-132C6375-274A-4E42-B0C4-BD2599D8ED5F

Q50663741-1ABFA352-3193-450D-9A29-46AD6F0224F6

Q50663741-720D549A-2DD0-4BC9-ABB7-1624700E7F47

Q50663741-80D9AD0D-0BE3-4A78-B045-43A514493DCA

Q50663741-95D5CB35-457E-491D-9E4D-9B3A4EF09724

Q50663741-B8E57D9C-27B9-409E-B8B3-FE2CCF30C8B8

Q50663741-FC1F3E4C-900D-41DF-A81C-3D30FE818F6E

Q50663741-FDB354A7-B3D9-44D1-BDEE-D6450C1ACF76

P2860

Q50663741-016C74F2-4B89-4202-BABD-B40B8FE99890

Q50663741-09E5EC76-5D8B-4A15-99FA-2C938AF3DCF3

Q50663741-0F287752-D583-4949-8CCC-F5EB75B24ADA

Q50663741-11472101-5D84-45F0-98CF-039F78D82964

Q50663741-12E4B4A2-1E57-4E0B-89E8-3049C59FA5EA

Q50663741-179C8353-D766-47D9-8946-BC94E16FF468

Q50663741-1CF18E4E-B844-4418-AF58-489115113C7A

Q50663741-1FEEF458-8DE2-4EE8-B141-5D1BBE9C9B54

Q50663741-22CF668C-9E6B-479F-8020-D2C395C8B1D1

Q50663741-2A643CA9-3F78-4E6D-8E59-5BA11E3B38DC

P304

Q50663741-6FBFA1D2-AF55-43CE-9FDC-FCABF5D29416

P31

Q50663741-9931381F-E1B0-4FAF-A3C8-F14001339C90

P356

Q50663741-A695C07F-F816-494D-93FA-09F72A41D11B

P407

Q50663741-2A8855B9-4F2B-4D74-8725-F1D3BF17A434

P433

Q50663741-78FE5E91-C921-437E-B4F3-A2A4A3719D4A

P478

Q50663741-1E7DBC33-2E0D-491F-B06B-3A177958D36C

P577

Q50663741-95685A4B-CB60-44A1-B59E-B46993F8A6C7

P5875

Q50663741-4F7D655C-16EE-41A2-A356-68BA8B160B6A

P698

Q50663741-061E29F1-76FC-48F6-B805-F6ED051BF679

P921

Q50663741-179CE703-D916-417D-A7B8-72F213C1655F

P356

P1433

P1476

Relationship of serum fibrosis ...... advanced chronic hepatitis C.

@en

P2093

Deepa Naishadham

http://www.w3.org/2001/XMLSchema#string

Elizabeth C Wright

http://www.w3.org/2001/XMLSchema#string

Grace L Su

http://www.w3.org/2001/XMLSchema#string

HALT-C Trial Group

http://www.w3.org/2001/XMLSchema#string

Herbert L Bonkovsky

http://www.w3.org/2001/XMLSchema#string

Jules L Dienstag

http://www.w3.org/2001/XMLSchema#string

Mita Ghosh

http://www.w3.org/2001/XMLSchema#string

Richard K Sterling

http://www.w3.org/2001/XMLSchema#string

Robert J Fontana

http://www.w3.org/2001/XMLSchema#string

Zachary D Goodman

http://www.w3.org/2001/XMLSchema#string

P2860

Histological grading and staging of chronic hepatitis

Diagnosis, management, and treatment of hepatitis C

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.

Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.

Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease.

Evaluation of liver fibrosis: a concise review.

American Gastroenterological Association technical review on the management of hepatitis C.

Noninvasive measures of liver fibrosis.

Liver fibrosis assessment with semiquantitative indexes and image analysis quantification in sustained-responder and non-responder interferon-treated patients with chronic hepatitis C.

Advances in digital quantification technique enhance discrimination between mild and advanced liver fibrosis in chronic hepatitis C.

P304

789-798

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.22099

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5675406

http://www.w3.org/2001/XMLSchema#string

P698

18175357

http://www.w3.org/2001/XMLSchema#string

P921